Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

NCT00509145 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1106

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Laquinimod
OTHER: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.